AAAAAA

   
Results: 1-14 |
Results: 14
Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems - Part IV. 2-alkyl substituents containing cationic heteroaromatics linked via a C-C bond
Authors: Azami, H Barrett, D Tanaka, A Sasaki, H Matsuda, K Sakurai, M Terasawa, T Shirai, F Chiba, T Matsumoto, Y Tawara, S
Citation: H. Azami et al., Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems - Part IV. 2-alkyl substituents containing cationic heteroaromatics linked via a C-C bond, BIO MED CH, 9(4), 2001, pp. 961-982
Orally active cephalosporins. Part 3: Synthesis, structure-activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins
Authors: Yamamoto, H Terasawa, T Nakamura, A Kawabata, K Takasugi, H Tanaka, H Matsumoto, S Matsumoto, Y Tawara, S
Citation: H. Yamamoto et al., Orally active cephalosporins. Part 3: Synthesis, structure-activity relationships and oral absorption of novel C-3 heteroarylmethylthio cephalosporins, BIO MED CH, 9(2), 2001, pp. 465-475
Mechanism of therapeutic effectiveness of cefixime against typhoid fever
Authors: Matsumoto, Y Ikemoto, A Wakai, Y Ikeda, F Tawara, S Matsumo, K
Citation: Y. Matsumoto et al., Mechanism of therapeutic effectiveness of cefixime against typhoid fever, ANTIM AG CH, 45(9), 2001, pp. 2450-2454
Studies on anti-Helicobacter pylori agents. Part 2: New cephem derivatives
Authors: Yoshida, Y Matsuda, K Sasaki, H Matsumoto, Y Matsumoto, S Tawara, S Takasugi, H
Citation: Y. Yoshida et al., Studies on anti-Helicobacter pylori agents. Part 2: New cephem derivatives, BIO MED CH, 8(9), 2000, pp. 2317-2335
Orally active cephalosporins. part 2: Synthesis, structure-activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chain
Authors: Yamamoto, H Terasawa, T Nakamura, A Kawabata, K Sakane, K Matsumoto, S Matsumoto, Y Tawara, S
Citation: H. Yamamoto et al., Orally active cephalosporins. part 2: Synthesis, structure-activity relationships and oral absorption of cephalosporins having a C-3 pyridyl side chain, BIO MED CH, 8(5), 2000, pp. 1159-1170
Orally active cephalosporins: Synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporins
Authors: Yamamoto, H Terasawa, T Ohki, A Shirai, F Kawabata, K Sakane, K Matsumoto, S Matsumoto, Y Tawara, S
Citation: H. Yamamoto et al., Orally active cephalosporins: Synthesis, structure-activity relationships and oral absorption of 3-[(E) and (Z)-2-substituted vinyl]-cephalosporins, BIO MED CH, 8(1), 2000, pp. 43-54
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis
Authors: Ikeda, F Wakai, Y Matsumoto, S Maki, K Watabe, E Tawara, S Goto, T Watanabe, Y Matsumoto, F Kuwahara, S
Citation: F. Ikeda et al., Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis, ANTIM AG CH, 44(3), 2000, pp. 614-618
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis
Authors: Matsumoto, S Wakai, Y Nakai, T Hatano, K Ushitani, T Ikeda, F Tawara, S Goto, T Matsumoto, F Kuwahara, H
Citation: S. Matsumoto et al., Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis, ANTIM AG CH, 44(3), 2000, pp. 619-621
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
Authors: Tawara, S Ikeda, F Maki, K Morishita, Y Otomo, K Teratani, N Goto, T Tomishima, M Ohki, H Yamada, A Kawabata, K Takasugi, H Sakane, K Tanaka, H Matsumo, F Kuwahara, S
Citation: S. Tawara et al., In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi, ANTIM AG CH, 44(1), 2000, pp. 57-62
FR192752, a novel orally active cephalosporin synthesis and biological properties
Authors: Yamamoto, H Kawabata, K Tawara, S Takasugi, H Tanaka, H
Citation: H. Yamamoto et al., FR192752, a novel orally active cephalosporin synthesis and biological properties, J ANTIBIOT, 53(10), 2000, pp. 1223-1227
In vitro antibacterial activity of FK041, a new orally active cephalosporin
Authors: Watanabe, Y Hatano, K Matsumoto, Y Tawara, S Yamamoto, H Kawabata, K Takasugi, H Matsumoto, F Kuwahara, S
Citation: Y. Watanabe et al., In vitro antibacterial activity of FK041, a new orally active cephalosporin, J ANTIBIOT, 52(7), 1999, pp. 649-659
In vivo antibacterial activity of FK041, a new orally active cephalosporin
Authors: Tawara, S Hatano, K Wakai, Y Matsumoto, S Watanabe, Y Matsumoto, F Kuwahara, S
Citation: S. Tawara et al., In vivo antibacterial activity of FK041, a new orally active cephalosporin, J ANTIBIOT, 52(7), 1999, pp. 660-665
FK463, a novel water-soluble echinocandin lipopeptide: Synthesis and antifungal activity
Authors: Tomishima, M Ohki, H Yamada, A Takasugi, H Maki, K Tawara, S Tanaka, H
Citation: M. Tomishima et al., FK463, a novel water-soluble echinocandin lipopeptide: Synthesis and antifungal activity, J ANTIBIOT, 52(7), 1999, pp. 674-676
Synthesis and biological properties of a novel cephalosporin FR86521 having potent activity against methicillin-resistant Staphylococcus aureus (MRSA)
Authors: Kishi, K Ohki, H Okuda, S Kawabata, K Sakane, K Matsumoto, Y Matsumoto, S Tawara, S
Citation: K. Kishi et al., Synthesis and biological properties of a novel cephalosporin FR86521 having potent activity against methicillin-resistant Staphylococcus aureus (MRSA), J ANTIBIOT, 52(12), 1999, pp. 1152-1155
Risultati: 1-14 |